Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises funds managed by Triton in connection with acquisition
Mandate

Vinge advises funds managed by Triton in connection with acquisition

April 30, 2018 Banking and Finance

Vinge has advised funds managed by Triton in connection with the acquisition of the privately owned company Mark & Energibyggarna i Göteborg AB, a supplementary acquisition to its portfolio company Akeab.

Mark & Energibyggarna is a successful supplier of services within facility construction in the Gothenburg area. Mark & Energibyggarna is connected to KEWAB and Akeab as a new sister company in an infrastructure group, focused on facility and construction work, owned by Triton and the management of the companies in question.

Vinge’s team consisted of partner Christina Kokko together with, among others, associates Oscar Rydén, Johanna Wiberg and Michaela Cronemyr. Partner Albert Wållgren and associates Adelwald and Sara Osman provided financing advice. Partner Marcus Glader and associates Xandra Ståhlberg and Fredrika Hjelmberg provided competition law advice.

Related

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

 A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023